Shiva Pharmachem files DRHP with SEBI for the proposed IPO; Key Details here

Shiva Pharmachem is into Chemicals Specialty Chemicals and is looking raise funds through Offer for Sale

Shiva Pharmachem to raise Fresh Issue of Equity shares up to and an Offer for Sale Equity shares aggregating up to Rs.900 crores IPO

Shiva Pharmachem IPO: Shiva Pharmachem Limited has filed Draft Red Herring Prospectus (DRHP) for proposed initial public offer (IPO) and raise funds through an offer of equity share capital having face value of Rs. per share via initial public offering.

Initial Public Offer comprising of a Offer for Sale of Equity Shares aggregating up to Rs. 900 crores.. JM Financial, Kotak Mahindra Capital have been appointed as lead merchant bankers for the proposed IPO. It has appointed Link Intime India Pvt. Ltd. as Registrar and Share transfer Agent. Company is yet to finalize issue size and some other important details relating to the IPO.

Details about upcoming IPO:
As per the details available in DRHP, fundraising will consist of an Equity Sharesby Vishal Rakesh Agrawal, Rahul Rakesh Agrawal and Geetganga Investment Private Limited who will offload Equity shares worth of up to Rs. 383 crores, up to Rs. 383 crores and up to Rs. 134 crores respectively...

Objects of the issue:
to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the Offer of the Equity Shares by the Selling Shareholders.

About Company:
Shiva Pharmachem established in 1999 is into Specialty Chemicals having over 20 years of experience in the Indian specialty chemicals business. Company has three manufacture plants and located at Luna (Gujarat), Dahej SEZ (Gujarat) and Sajóbábony (Hungary). Company is also backward integrated for most of key products. Company is having dedicated R&D team and developed in-house technology for all products including bulk acid chlorides and specialty chemicals. Customer base is diverse, and served to over 181 multinational, and domestic companies in FY23. In FY23, Exported products to 22 countries in FY23.

About Industry:
The global chemicals industry is expected to grow from US$5,348 billion in CY2022 to US$7,445 billion in CY2027 at a CAGR of 6.8%. The Indian chemicals industry has emerged as a key player with a global marketshare of approximately 4%by valuein CY2022. India’s chemicals industry is de-licensed, except for few hazardous chemicals. India holds a strong position in exports of chemicals at a global level and ranks 14th in exportsfor CY2022.India is a key importer of chemicals ranking 8th at a global level by value in CY2022.

Source: SEBI, BSE, NSE, DRHP, Company, Industry Data

Disclaimer: Above article only publishes details about the IPO for educational purpose and doesn't solicit or invite any interest to invest. Please visit respective sources to verify and know more details about the IPO. We advise investors to take opinion from certified/SEBI registered experts before taking any investment decisions.